CBDY 8k https://www.sec.gov/Archives/edgar/data/15
Post# of 37072
On June 15, 2021, the Company distributed a newsletter to its shareholders announcing that its wholly owned subsidiary, CanaryRx Inc., has received its Health Canada sales license which will permit Canary Rx Inc. to manufacture and sell cannabis products directly to provincial distributors and other authorized Canadian retail supply channels